Search results
How Can Parents Prevent Asthma in Babies?
Healthline· 4 days agoAsthma is a complex lung disease that results from many different genetic and environmental risk factors. No single strategy can prevent asthma, but you...
New drug benefits patients with Sjögren's disease in phase 2 clinical trial
Medical Xpress· 2 days agoSJD is marked by eye and mouth dryness, fatigue, and pain and often occurs in association with rheumatoid arthritis and systemic lupus, but it can also be its own primary disease< ...
Former lab workers deemed 'high risk' now eligible for annual lung cancer screenings
Tribune via AOL· 2 days agoJun. 5—Former Los Alamos National Laboratory and Sandia National Laboratories employees who are deemed "high risk" will be eligible for a new early lung cancer screening program ...
Eko Health captures $41M to expand AI stethoscope business worldwide
FierceBiotech· 23 hours agoWith previous regulatory green lights for detecting structural heart murmurs and atrial fibrillation...
MyMichigan Health: Vaping: Safe? Or are your lungs going up in smoke?
Midland Daily News· 7 days agoVaping, a process of inhaling an aerosolized material into the lungs, has become increasingly...
Socioeconomic status can influence genetic risk for many complex diseases
Medical Xpress· 6 days agoUsing biobank and national register data, researchers from Finland have now found that people with...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe Tagrisso regimen is intended for treating patients with locally advanced or metastatic epidermal...
...Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20...
The Woonsocket Call· 5 days ago...June 2, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, presented the latest data from the inaugural global pivotal study WU-KONG1 Part B (WU-KONG1B) of sunvozertinib in relapsed...
Newswise Expert | Afshin Dowlati, Case Western Reserve University
Newswise· 14 hours agoMy research is focused on the translational aspects of target validation and drug development and I am uniquely positioned to perform preclinical studies of novel drugs in cancer models with ...
RYBREVANT® (amivantamab-vmjw) plus lazertinib is the only chemotherapy-free regimen showing longer...
Tri-County Times· 7 days agoResults from the new analysis show the RYBREVANT® combination consistently and significantly improved progression-free survival (PFS...